The management of infections by multiresistent bacteria in patients undergoing solid organ transplant now be regarded as one of the greatest challenges in these patients.The pathogens in particular (Staphylococci, Enterococci spp and Klebsielle spp) are very often with variability from center to center germs more frequently isolated in such patients. And ‘understandable then as the possibility of using a new antibiotic active against these pathogens, with excellent tolerability and pharmacology no interference with drugs that would normally take these patients
New Therapeutic Opportunity in Managment of Infection By Multiresitant Germs in Patients Undergoing Solid Organ Transplantation. Role of A New Tetraciclin Tigecicline / Ferretti, GIAN CARLO; Rossi, Massimo; Novelli, G; Poli, Luca; Ferretti, S; Mancini, Carlo; Raponi, Giammarco; G, ; Ghezzi, Maria Cristina; Pugliese, F.. - In: TRANSPLANTATION. - ISSN 0041-1337. - 86:(2008), pp. 396-396. [10.1097/01.tp.0000331640.85861.d9]
New Therapeutic Opportunity in Managment of Infection By Multiresitant Germs in Patients Undergoing Solid Organ Transplantation. Role of A New Tetraciclin Tigecicline.
FERRETTI, GIAN CARLO;ROSSI, MASSIMO;POLI, Luca;MANCINI, Carlo;RAPONI, Giammarco;GHEZZI, Maria Cristina;PUGLIESE F.
2008
Abstract
The management of infections by multiresistent bacteria in patients undergoing solid organ transplant now be regarded as one of the greatest challenges in these patients.The pathogens in particular (Staphylococci, Enterococci spp and Klebsielle spp) are very often with variability from center to center germs more frequently isolated in such patients. And ‘understandable then as the possibility of using a new antibiotic active against these pathogens, with excellent tolerability and pharmacology no interference with drugs that would normally take these patientsI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
